Pharmacy | Home | MIMS Malaysia

Malaysia
Search
Sign In

Pharmacy

Pharmacy

Home News Conferences Special Reports Multimedia

EBRT-stenting combo improves survival in patients with malignant airway obstruction

19 hours ago

Patients with malignant airway obstruction (MAO) appear to have better survival with combination therapy with stenting plus external beam radiotherapy (EBRT) compared to stenting or EBRT alone, according to the results of a retrospective analysis.

Steroids confer therapeutic renal benefit for IgA nephropathy

Audrey Abella, 20 hours ago

Corticosteroids may protect renal function and reduce proteinuria in patients with immunoglobulin A nephropathy (IgAN), a chronic glomerular disease that may gradually progress to end-stage renal disease (ESRD), according to a meta-analysis.

Latanoprost safe for children with glaucoma, ocular hypertension

Jairia Dela Cruz, 20 hours ago

The prostaglandin analogue latanoprost demonstrates an acceptable safety profile in the long-term treatment of paediatric patients with glaucoma and ocular hypertension, with no evidence of clinically meaningful changes in ocular development or hyperpigmentation, according to the results of a 3-year safety study of the drug.

Future TTR in atrial fibrillation patients on VKA

Yesterday

Nearly half of atrial fibrillation (AF) patients on vitamin K antagonist (VKA) with prior time in therapeutic range (TTR) ≥70 percent had TTR <70 percent during the following year, reports a recent study. Additionally, there is limited long-term prognostic value for prior TTR ≥70 percent.

Baricitinib tapering in RA may lead to increased disease activity for some patients

Jairia Dela Cruz, Yesterday

Rheumatoid arthritis (RA) disease control appears to be better with continued 4-mg baricitinib treatment than with a 2-mg dose step-down approach, according to substudy data from the ongoing phase III RA-BEYOND extension trial.

Candida albicans predicts FMT response for C. difficile infection

Jackey Suen, Yesterday

In patients receiving foecal microbiota transplantation (FMT) for the treatment of Clostridium difficile infection (CDI), high levels of Candida albicans may be associated with poor outcomes, a recent study has shown.

Optimizing hypertension management in clinical practice with nebivolol

Prof. Giuseppe Mancia, Prof. Jong-Won Ha, Prof. Lin Jiunn-Lee, 11 Jul 2018

Hypertension guidelines diﬀer in their recommendation to use beta-blockers as ﬁrst-line agents. At a Menarini-sponsored symposium held during the Asian Paciﬁc Society of Cardiology Congress 2018 in Taipei, Taiwan, Professor Giuseppe Mancia from the University of Milano-Bicocca in Milan, Italy and Professor Jong-Won Ha from the Yonsei University College of Medicine in Seoul, Korea discussed the rationale behind these recommendations, and reviewed the role of beta-blockers in hypertension management, particularly the role of vasodilatory beta-blocker nebivolol (Nebilet^®, Menarini). Professor Lin Jiunn-Lee, APSC 2018 chairman and president of the Taiwan Society of Cardiology, chaired the symposium.

Improving Medical Practice through Advancement in Clinical Treatment: IMPACT Aesthetics & Suturing Workshop 2018

Dr. Steven Ang, Dr. Leo Kah Woon, 11 Jul 2018

DCH Auriga recently held their first Aesthetics and Suturing Workshop under the IMPACT continuing medical education series – a scientific platform that aims to cascade the latest updates on disease management and share best clinical practices among healthcare professionals in Singapore. Two experts on aesthetics and aesthetic surgery shared their insights on suturing techniques and current approaches for scar prevention and management.

Excerpts from the expert meeting on the use of topical NSAIDs in musculoskeletal pain

01 Jul 2018

With the objective of establishing a Malaysian consensus on the use of topical NSAIDs in the management of musculoskeletal pain, this meeting brought together experts from various backgrounds, ie, rheumatology, pharmacy, orthopaedics and general medicine. At the meeting, Dr Mary Suma Cardosa delivered a talk on the pathophysiology and effective management of pain, while the lecture by Dr Yeap Swan Sim focused on the management of musculoskeletal and soft-tissue pain. This article presents excerpts from the expert meeting and features the consensus statements agreed during the meeting.

Factor Xa inhibitor failed in reducing mortality among heart failure patients without AF

Dr. Joseph Delano Fule Robles, 30 Aug 2018

The factor Xa inhibitor rivaroxaban failed in reducing the risk of death, MI or stroke as compared with placebo among patients with worsening chronic heart failure (HF) and underlying coronary artery disease (CAD) without atrial fibrillation (AF), according to results of the COMMANDER HF trial reported at the European Society of Cardiology (ESC) Congress 2018.

CAMELLIA–TIMI 61: Lorcaserin first weight-loss agent to show CV safety in high-risk patients

Jackey Suen, 30 Aug 2018

Lorcaserin has become the first weight-loss agent to show cardiovascular (CV) safety in patients at high CV risk, according to results of the CAMELLIA–TIMI 61 study presented at the European Society of Cardiology (ESC) Congress 2018.

Younger lymphoma patients may be less susceptible to chemo-induced ovarian toxicity

Pearl Toh, 27 Aug 2018

Chemotherapy may be less damaging to fertility of female lymphoma patients who are of a younger age than those who are older, even in the case of an alkylating regimen, suggests a study presented at ESHRE 2018.

No harms on offspring cognition with peripartum ART

Pearl Toh, 21 Aug 2018

Use of triple antiretroviral therapy (ART) during pregnancy and breastfeeding did not affect the cognitive development and function of the offspring compared with those whose mothers were not exposed to ART, reveals the IMPAACT PROMISE-BF study presented at the IAC 2018.

Dual therapy comparable with triple therapy for initial HIV-1 treatment

Roshini Claire Anthony, 18 Aug 2018

The combination of dolutegravir + lamivudine appeared noninferior to dolutegravir + tenofovir/emtricitabine in reducing viral load in treatment-naïve patients with HIV-1 infection, according to the phase III GEMINI-1 and GEMINI-2* trials presented at AIDS 2018.

Is dolutegravir monotherapy safe as maintenance for HIV patients?

Pearl Toh, 17 Aug 2018

Simplification from combination antiretroviral therapy (cART) to dolutegravir monotherapy as maintenance treatment was noninferior to continuing therapy with cART, at least in patients who initiated cART during primary HIV infection and had achieved suppressed viral load for ≥48 weeks, suggests a study presented at IAC 2018.

Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!